BriaCell Therapeutics Corp.
BCTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001610820
No open-market purchases or sales by BriaCell Therapeutics Corp. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $1.58M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in BriaCell Therapeutics Corp. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +14 vs. Q1 2021
- Shares held
- 3.80M
- +3.43M (+913.2%) vs. Q1 2021
- Total value
- $20.3M
- +$18.8M (+1,300.5%) vs. Q1 2021
- New holders
- 16
- 5 more added
- Sold out
- 2
- 2 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $1.58M |
| Q1 2026 | 16 | $1.62M |
| Q4 2025 | 13 | $69.2K |
| Q3 2025 | 13 | $136.5K |
| Q2 2025 | 16 | $181.1K |
| Q1 2025 | 14 | $94.1K |
| Q4 2024 | 26 | $379.1K |
| Q3 2024 | 22 | $538.1K |
| Q2 2024 | 20 | $452.0K |
| Q1 2024 | 20 | $6.38M |
| Q4 2023 | 26 | $14.6M |
| Q3 2023 | 21 | $17.0M |
| Q2 2023 | 21 | $17.9M |
| Q1 2023 | 21 | $19.4M |
| Q4 2022 | 21 | $12.3M |
| Q3 2022 | 22 | $14.3M |
| Q2 2022 | 22 | $17.0M |
| Q1 2022 | 18 | $33.5M |
| Q4 2021 | 20 | $10.9M |
| Q3 2021 | 21 | $4.77M |
| Q2 2021 | 24 | $20.3M |
| Q1 2021 | 10 | $1.45M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding BriaCell Therapeutics Corp.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 12 | $0 | 0.00% | −6,000−99.8% | Reduced |
| Royal Bank of Canada | 7 | $0 | 0.00% | −10−58.8% | Reduced |
| Harbour Investments, Inc. | 185 | $1.00K | 0.00% | +20+12.1% | Added |
| Toronto Dominion Bank | 842 | $5.00K | 0.00% | +830+6,916.7% | Added |
| Tower Research Capital LLC (TRC) | 3,288 | $18.0K | 0.00% | +3,288 | New |
| Advisory Services Network, LLC | 4,500 | $24.0K | 0.00% | +4,500 | New |
| Goldman Sachs Group Inc | 11,108 | $59.0K | 0.00% | +11,108 | New |
| UBS Group AG | 13,308 | $71.0K | 0.00% | +12,676+2,005.7% | Added |
| Two Sigma Advisers, LP | 16,900 | $90.0K | 0.00% | +16,900 | New |
| Morgan Stanley | 18,227 | $97.0K | 0.00% | +18,227 | New |
| Eqis Capital Management, Inc. | 21,182 | $113.0K | 0.01% | +4,843+29.6% | Added |
| Bank of America Corp | 22,349 | $119.0K | 0.00% | +22,349 | New |
| Verition Fund Management LLC | 22,311 | $119.0K | 0.00% | +22,311 | New |
| Summit Trail Advisors, LLC | 35,000 | $187.0K | 0.02% | +35,000 | New |
| Marshall Wace, LLP | 63,226 | $337.0K | 0.00% | +63,226 | New |
| Redmond Asset Management, LLC | 131,731 | $702.0K | 0.21% | 00.0% | Unchanged |
| Sabby Management, LLC | 196,033 | $1.04M | 0.23% | +35,851+22.4% | Added |
| Murchinson Ltd. | 250,000 | $1.33M | 0.49% | +250,000 | New |
| CVI Holdings, LLC | 320,800 | $1.71M | 0.12% | +320,800 | New |
| MMCAP International Inc. SPC | 400,000 | $2.13M | 0.19% | +400,000 | New |
| Hudson Bay Capital Management LP | 400,000 | $2.13M | 0.03% | +400,000 | New |
| Kepos Capital LP | 500,000 | $2.67M | 0.20% | +500,000 | New |
| Armistice Capital, LLC | 570,343 | $3.04M | 0.08% | +570,343 | New |
| Altium Capital Management LP | 800,295 | $4.27M | 0.99% | +800,295 | New |
| Zeke Capital Advisors, LLC | 0 | $0 | 0.00% | −45,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −15,121−100.0% | Sold out |